NeuroOne Medical Technologies Corporation (NMTC)
$1.10+1.85%Close
SELLCRISIS · day 34
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 0.64
- P/E (TTM)
- -1.20
- Short % float
- 2.60%
- Days to cover
- 1.2
- SI change
- +135.8%
- 1W
- -2.65%
- 1M
- -26.67%
- vs SPY 1W
- -2.52%
- vs SPY 1M
- -29.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 6
- VALUE
- 8
- GROWTH
- 40
- GARP
- 7
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-75.9%
REV YoY-
ROE-126.4%
EPS YoY-
ROA-115.6%
GROSS56
OP-76
NET-72
[VALUATION]
P/E TTM-1.20
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B2.53
P/FCF-
EV/EBITDA-1.10
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.95
ALTMAN Z-
CURR RATIO2.84
ND/EBITDA-
BETA0.64
Company news
FAQ
- What is LOPJLB’s current signal on NMTC?
- LOPJLB’s latest quantitative signal on NeuroOne Medical Technologies Corporation (NMTC) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NMTC in?
- NeuroOne Medical Technologies Corporation (NMTC) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does NeuroOne Medical Technologies Corporation (NMTC) do?
- NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as th…